Introduction
Cyclin-dependent kinase (CDK) p34 cdc2 plays an essential role in cell cycle progression, and its kinase activity is under complicated but very tight regulation during the cell cycle. p34 cdc2 alone is not active as its protein kinase activity is strictly dependent on association with cyclin B, whose level¯uctuates during the cell cycle. p34 cdc2 also undergoes post-translational modi®cation via reversible phosphorylation. For example, CAK (CDK-activating kinase) phosphorylates p34 cdc2 on threonine 161, activating the kinase, whereas Wee1 kinase phosphorylates p34 cdc2 on tyrosine 15 (Tyr15) and threonine 14 (thr14), inactivating the kinase (Feilotter et al., 1992; Norbury et al., 1992) . On the other hand, the Cdc25C gene product, a dual speci®c phosphatase, dephosphorylates p34 cdc2 on Tyr 15 and Thr 14 and, thus, positively regulates p34 cdc2 kinase activity (Feilotter et al., 1992; Norbury et al., 1992) .
In human, three structurally related genes exist in the Cdc25C family (Galaktionov and Beach, 1991) ; they are named Cdc25C A, B, and C. Cdc25A appears to be involved primarily in G1 progression and G1/S transition (Galaktionov et al., 1996) . Cdc25B is essential for cell cycle progression, possibly regulating G2/M transition as a`starter' phosphatase (Lammer et al., 1998) . Among the three Cdc25 family genes, Cdc25C is best characterized. Cdc25C is activated in G2, and its activity is critical for the onset and progression of mitosis (Sadhu et al., 1990) . In Xenopus, Cdc25C is a phosphoprotein and is heavily phosphorylated by kinases other than Cdc2 and Cdk2 during G2 (Izumi and Maller, 1995) .
In the past few years, an emerging family of protein kinases (the polo kinase family) has been described in yeast (Kitada et al., 1993) , Drosophila (Llamazares et al., 1991) , Xenopus (Kumagai and Dunphy, 1996) , mouse (Simmons et al., 1992; Golsteyn et al., 1995; Donohue et al., 1995) , and human (Hamanaka et al., 1994; Li et al., 1996 ; also see recent review Nigg, 1998) . The Drosophila polo gene, homologous to the budding yeast Cdc5, encodes a serine/threonine (Ser/Thr) kinase and is required for mitosis in this species; mutations in this gene result in abnormal mitotic and meiotic division (Fenton and Glover, 1993) . The abnormalities of these mutants are manifested as over-condensed chromosomes, abnormal spindle formation, and polyploidy (Llamazares et al., 1991; Fenton and Glover, 1993) . polo transcripts are abundantly expressed in tissues and developmental stages that display extensive mitotic activity. The polo kinase activity peaks cyclically at anaphase/telophase (Llamazares et al., 1991; Fenton and Glover, 1993) .
The human has at least three genes, plk (Hamanaka et al., 1994) , prk (Li et al., 1996) and snk (GenBank accession #AF059617), whose structures are related to Drosophila. We have previously reported the cloning and characterization of a cDNA coding for human prk (proliferation-related kinase or polo-related kinase) (Li et al., 1996) . Subsequently, we demonstrate that Prk is involved in regulating M phase functions (Ouyang et al., 1997) . Our current studies report Prk's mode of action during cell cycle regulation. We show that Prk speci®cally interacts with and phosphorylates Cdc25C protein phosphatase.
Results
Our early studies have demonstrated the role of prk in the regulation of mitosis and meiosis (Ouyang et al., 1997) . Our preliminary study also shows that Prk phosphorylates Cdc25C in vitro (Ouyang et al., 1997) . To study the mode of action of Prk during cell cycle regulation, we expressed both human His6-Prk and His6-Cdc25C in insect sf-9 cells through the baculoviral vector expression system. Figure 1a shows that Prk antigen is expressed in sf-9 cells infected with either His6-Prk baculovirus (lane 5) or His6-Prk/His6-Cdc25C baculoviruses (double-infection, lane 3). The same blot was stripped and reprobed with the antiCdc25C antibody. Figure 1b shows that Cdc25C antigen is detected in His6-Cdc25C baculovirusinfected cells (lane 4) or the double-infected cells (lane 3). We also expressed His6-tagged Cdc25C in E. coli using a prokaryotic expression vector. As shown in Figure 1b , Cdc25C was highly induced after IPTG addition (lane 1) as compared with the non-induced bacterial lysates (lane 2). Figure 1c illustrates the Commassie blue stained blot as a loading control.
We puri®ed recombinant His6-Prk and His6-Cdc25c proteins using anity chromatography. Puri®ed His6-Prk was analysed for in vitro kinase activity using casein or His6-Cdc25C as a substrate. Figure 2a shows that His6-Prk strongly phosphorylated casein (CSN, lanes 1 and 4) but not histone H1 (data not shown) in vitro. His6-Prk also phosphorylated the puri®ed His6-Cdc25C in vitro (Figure 2a, lanes 3 and 4) . To determine whether His6-Prk phosphorylates other members of the Cdc25 family, we expressed and puri®ed GST-Cdc25A and GST-Cdc25B. An equal amount of the puri®ed Cdc25 proteins were used for in vitro kinase assays. It was shown (Figure 2b ) that His6-Prk phosphorylated all three GST-Cdc25 proteins in vitro. It appears that His-Prk phosphorylated Cdc25C (lane 3) more eciently than it did Cdc25A (lane 1) or Cdc25B (lane 2). To eliminate the possibility that a contaminated protein kinase activity was co-puri®ed with His6-Prk and, was thus actually responsible for the phosphorylation of Cdc25 proteins, we changed a conserved lysine residue (amino acid #52, Ouyang et al., 1997) in the kinase domain of His6-Prk into an arginine residue via site-directed mutagenesis. The mutated molecule His6-Prk K52R was expressed, puri®ed, and assayed for its kinase activity in the same manner as was the wild-type His6-Prk. Figure 2c shows that His6-Prk K52R weakly phosphorylated His6-Cdc25C (lane 4) whereas His6-Prk phosphorylated His6-Cdc25C eciently (lane 3), indicating that Prk is the primary kinase that phosphorylates the phosphatase. Titration experiments con®rmed that Prk K52R had a Many physiological substrates of protein kinases form a relatively stable complex with the enzymes, which can be detected by co-immunoprecipitation. To determine whether Prk and Cdc25C proteins directly interact with each other, we immunoprecipitated protein lysates from sf-9 cells infected with His6-Prk or His6-Cdc25C or both recombinant baculoviruses. Immuno-precipitates were analysed by SDS ± PAGE followed by Western blotting using the anti-Prk antibody. Figure To ascertain whether Prk interacts with native Cdc25C, we expressed the C-terminal half of Prk as a GST-fusion protein. GST-Prk, as well as control proteins GST-K11 (an RNA-binding factor) or GST, were immobilized to glutathione Sepharose resins as described in the Experimental procedures. Cell lysates (1610 8 cell equivalent) of Dami cells were incubated with the immobilized GST-Prk, GST-K11, or GST protein (50 mg each). After incubation, the Sepharose resins were thoroughly washed. Proteins bound to GST-Prk, GST-K11 or GST resins were eluted and analysed by SDS ± PAGE followed by Western blotting using the anti-Cdc25C antibody. Figure 4a shows that Cdc25C antigen was detected in GST-Prk eluent (lane 2), but not in the eluent of GST alone (lane 3) or GST-K11 (lane 4), indicating that Cdc25C speci®cally interacts with the C-terminal half of Prk. To con®rm that approximately equal amounts of each`bait' protein were used in the binding, the same blot was stained with Commassie brilliant blue (Figure 4b ). It was noted that roughly equal amounts of GST-Prk, GST, or GST-K11 protein were used in the binding although GST-Prk and GST-K11 (Figure 4b , lanes 2 and 4) were partially degraded.
To further determine whether endogenous Prk and Cdc25C interact with each other at a physiological concentration, Cdc25C immunoprecipitates from PC-3 cells were analysed for the presence of Prk antigen by Western blotting. Figure 5a shows that anti-Cdc25C antibody (lane 2) but not a control antibody (lane 1) brought down the Prk antigen. We were unable to detect Cdc25C antigen in Prk immunoprecipitates via Western blotting. We suspected that the anti-Prk antibody may somehow interfere with Cdc25C's association with Prk, and thus reduce interaction eciency of Cdc25C protein with Prk during immunoprecipitation. To increase detection sensitivity, we metabolically labeled PC-3 cells with 32 P-phosphate. Immunoprecipitation of labeled lysates shows ( Figure  5b ) that the anti-Prk antibody, but not the anti-b-actin antibody (data not shown), is capable of bringing down a protein co-migrating with in vitro phosphorylated His6-Cdc25C (lane 1) or Cdc25C immunoprecipitated from PC-3 cell lysates (lane 3). This suggests that Cdc25C physically interact with Prk.
The question of whether Prk phosphorylates Cdc25C was further studied by immunoprecipitating His6-Cdc25C from various sf-9 cell lysates using an anti-Cdc25C antibody. The immunoprecipitates were analysed by Western blotting for Cdc25C expression. It was observed that there was a new Cdc25C antigen, with a slow mobility, in doubly-infected cell lysates (Figure 6a, lanes 4 and 6) . This Cdc25C antigen was not present in sf-9 cells infected with Cdc25C baculovirus alone (Figure 6a, lane 3) , suggesting the slow-mobility Cdc25C antigen is a phosphorylation product of Prk. A pretreatment of cell lysates with protein phosphatase converted the slow-moving bands into the fast-moving one (data not shown). To con®rm that Cdc25C is associated with Prk in vivo and that Cdc25C-associated kinase is capable of phosphorylating the protein phosphatase, His6-Cdc25C immunoprecipitated from equal amounts of cell lysates coinfected with His6-Prk or with His6-Prk K52R baculoviruses was directly incubated with [g 32 P]ATP in the kinase buer. After incubation, the reaction mixture was analysed by SDS ± PAGE followed by autoradiography. Figure 6b shows that His6-Cdc25C was phosphorylated strongly in cells co-infected with His6-Prk baculoviruses (lane 1) but weakly in cells co-infected with His6-Prk K52R baculoviruses (lane 3). Western blotting showed that both His6-Prk and His6-Prk K52R were expressed at similar levels in these cells (data not shown). This suggests that Prk was the primary kinase phosphorylating His6-Cdc25C. Additional experiments were also performed in which various sf-9 cell lysates were immunoprecipitated with the anti-Prk antibody, and Prk immunoprecipitates were analysed for kinase activity without addition of exogenous substrates. It was observed that His6-Prk, immunoprecipitated from doubly-infected sf-9 cells or the cells infected with His6-Prk baculovirus alone, was autophosphorylated (Figure 6c, lanes 3 and 4) . As expected, a protein migrating at about 60 kDa was coimmunoprecipitated with, and phosphorylated by His6-Prk in doubly-transfected (25C/Prk, lane 4). No such protein was present in cells infected with the wild-type (lane 1), His6-Prk (lane 3), or His6-Cdc25C (lane 2) baculovirus alone, strongly suggesting that Cdc25C is an in vivo substrate of Prk.
To determine whether Prk phosphorylates Cdc25C at physiologically relevant sites, Cdc25C puri®ed from metabolically-labeled asynchronized PC3 cells, as well as His6-Cdc25C phosphorylated in vitro by His6-Prk, were subjected to peptide mapping as described in the Experimental procedures. Figure 7a shows that the phosphopeptide map of His6-Cdc25C phosphorylated by His6-Prk in vitro yielded two discrete spots. This map was similar to the one obtained with Cdc25C phosphorylated in vivo (Figure 7a) . Mixing experiments showed that the major spot from in vitro experiments superimposed with the spot of in vivo experiments, strongly suggesting that His6-Prk phosphorylated His6-Cdc25C at a site that is also phosphorylated in vivo. It is known that the major phosphorylation site on Cdc25C in asynchronized cells is serine 216 (Ogg et al., 1994) . Therefore, we used an equal amount of puri®ed mutant GST-Cdc25C S216A (200 ± 256) peptide motif with serine 216 converted to alanine as well as the wild-type GST-Cdc25C(200 ± 256) peptide motif as in vitro substrates of His6-Prk. These peptides were originally used for assays for Chk1 and Chk2 protein kinase activities as reported (Sanchez et al., 1997; Matsuoka et al., 1998) . 
Discussion
Several previously characterized protein kinases have been implicated in phosphorylating and regulating the activity of Cdc25C. It has been shown that P1x1, a Xenopus Plk, physically associates with and phosphor- 4) . The immunoprecipitates were subjected to in vitro kinase assays without addition of exogenous substrates followed by SDS ± PAGE and autoradiography as described in B ylates Cdc25 protein (Kumagai and Dunphy, 1996) . The P1x1-phosphorylated Cdc25 has an enhanced activity towards its substrate p34 cdc2 (Kumagai, and Dunphy, 1996) , suggesting that P1x1 is a regulator for Cdc25. On the other hand, it has been demonstrated that P1k1 may be a substrate of p34 cdc2 and be involved in regulating the activity of anaphase-promoting complex (Kotani et al., 1998) , and that P1x1 is essential for degradation of a mitotic regulator and for exit from M phase (Descombes and Nigg, 1998). These observations suggest that P1k1 may have an additional, if not the primary, role during the progression of mitosis. Recently, it has been shown that c-Tak1, as well as the DNA damage checkpoint kinases Chk1 and Chk2, phosphorylate Cdc25C on serine 216 (Peng et al., 1997 (Peng et al., , 1998 Matsuoka et al., 1998) . Phosphorylation of Cdc25C on serine 216 by chk1 and chk2 gene products apparently does not directly modulate its phosphatase activity, instead it promotes 14 ± 3 ± 3 protein binding (Sanchez et al., 1997; Peng et al., 1997) . 14 ± 3 ± 3 protein then sequestrates Cdc25C in cytoplasm resulting in down-regulation of Cdc25C enzymatic activity in vivo (Lopez-Girona et al., 1999) .
We and others have previously shown that prk (Ouyang et al., 1997) and plk (Lee and Erikson, 1997) genes are functional homologues of the budding yeast CDC5. We have also demonstrated that Prk's kinase activity is regulated during the cell cycle peaking at late S and G2 stages although M phase cells also contain a considerable amount of Prk activity (Ouyang et al., 1997) . In this paper, we report that puri®ed His6-Prk, but not His6-Prk K52R , is capable of strongly phosphorylating His6-Cdc25C in vitro. Using the co-immunoprecipitation approach, we have shown that His6-Prk interacts with His6-Cdc25C expressed in sf-9 cells as well as with native Cdc25C from PC-3 cells. In addition, His6-Prk is capable of phosphorylating His6-Cdc25C molecules in vitro at a site that is also phosphorylated in vivo in asynchronized cells. Considering that the activity of Cdc25C is regulated via reversible phosphorylation (Izumi and Maller, 1995; Kumagai and Dunphy, 1996) , our current studies strongly suggest that Prk is a cellular regulator for Cdc25C.
It is intriguing to note that His6-Prk phosphorylates His6-Cdc25C in vitro on serine 216 (Figure 7 ). This is a site whose phosphorylation would lead to inactivation of Cdc25C activity due to sequestration in cytoplasm by 14 ± 3 ± 3 (Lopez-Girona et al., 1999), which is apparently inconsistent with Prk's role in complementation of CDC5 mutants (Ouyang et al., 1997) . However, one likely explanation is that Prk may be involved in down-regulation of p34 cdc2 activity during late mitosis because considerable Prk activities remain during mitosis (Ouyang et al., 1997) . It has been established that activation of p34 cdc2 is controlled not only by its association with cyclin B but also by reversible phosphorylation. It is possible that inactivation of p34 cdc2 at late mitosis is also controlled by multiple mechanisms. Namely, in addition to degradation of cyclin B, inactivation of p34 cdc2 is reinforced by sequestration in cycoplasm of Cdc25C that has been phosphorylated on serine 216 by kinases such as Prk and perhaps Plk. This notion is, in fact, consistent with the observation that CDC5 ts mutants are arrested at late mitosis, a phenotype similar to accumulation of nondegradable cyclin B in mammalian cells. It is also consistent with the recent observation that P1x1 is required for exit from mitosis in Xenopus (Descombes and Nigg, 1998 ).
An alternative explanation of serine 216 phosphorylation of Cdc25C by Prk is that the kinase may be regulated by DNA damage checkpoint because CDC5 from the budding yeast participates in adaptation of DNA-damage-induced cell arrest (Toczyski et al., 1997) . One may propose that Prk expression and/or its activity may be down-regulated in response to DNA damage considering that Prk complements CDC5 ts mutant (Ouyang et al., 1997) and thus promoting cell cycle progression. Whether or not Prk is downregulated during DNA damage is under current investigation. On the other hand, signals other than DNA damage may also elicit serine 216 phosphorylation of Cdc25C. For example, c-Tak-1 kinase is a very active serine 216 kinase of Cdc25C (Peng et al., 1998) .
It is yet to be demonstrated whether c-Tak-1 is activated by DNA damage checkpoint. In addition, Cdc25C is phosphorylated during G1, S, and G2 (Ogg et al., 1994) in the absence of DNA damage or un-replicated DNA. Therefore, it is clear that protein kinases other than Chk1 and Chk2 are phosphorylating Cdc25C on serine 216 during normal progession of the cell cycle.
Materials and methods

Cell culture
Insect sf-9 cells were cultured at 278C in Grace's insect medium supplemented with 10% fetal bovine serum (FBS, Hyclone, Logan, UT, USA) and antibiotics (100 U/ml penicillin, 50 mg/ml streptomycin sulfate, and 50 mg/ml gentamicin, GIBCO/BRL). Dami (megakaryoblastic, ATCC, Rockville, MD, USA) and PC-3 (prostatic carcinoma, ATCC) cells were grown in RPMI1640 medium, supplemented with 10% FBS, at 378C with 5% CO 2 .
GST-Fusion protein expression and Western blotting
GST-Cdc25A, GST-Cdc25B, GST-p34 cdc2 and Prk (amino acids 334 ± 607, Ouyang et al., 1997) were expressed as glutathione s-transferase (GST) fusions. Fusion proteins were induced by isopropyl-b-D-thiogalactopyranoside (IPTG) and puri®ed through anity column chromatography using glutathione sepharose resins according to the protocol provided by the supplier. GST-Cdc25C (200 ± 256) and its mutant GST-Cdc25 C S216A (200 ± 256) fusion proteins were kindly provided by Yolanda Sanchez. Mouse monoclonal anti-Prk antibody was produced against an epitope in the Cterminal half of Prk (Ouyang et al., 1997) . Mouse monoclonal anti-Cdc25C antibody was produced using the full length of Cdc25C as an immunogen. Both antibodies are available from PharMingen Inc. (San Diego, CA, USA). A rabbit polyclonal anti-Cdc25C antibody was purchased from Santa Cruz Biotech Inc. (Santa Cruz, CA, USA). Western blot analyses were described previously (Ouyang et al., 1997) .
Expression and puri®cation of recombinant human Prk
Full-length recombinant Prk was expressed using the baculoviral expression system (PharMingen) following the manufacturer's protocol. Brie¯y, a cDNA fragment containing the entire open reading frame of human prk was cloned into PVL-1393 transfer vector. To facilitate puri®cation of recombinant Prk protein, a short nucleotide sequence coding for six histidine residues was inserted in-frame immediately ) was generated using a site-directed mutagenesis kit (GIBCO/ BRL). His6-Prk K52R was expressed in and puri®ed from sf-9 cells in the same manner as His6-Prk. Recombinant baculoviruses expressing His6-Cdc25C and GST-Wee1 were kindly provided by Dr Piwnica-Worms (Howard Hughes Medical Institute, Washington University School of Medicine, USA). Insect sf-9 cells expressing recombinant His6-Prk and His6-Cdc25C were harvested and lysed for analysis or for puri®cation of recombinant proteins using Ni-NTA resins (Qiagen, Chatworth, CA, USA).
Immunoprecipitation and protein kinase assays
Immunoprecipitation and immunocomplex kinase assays were essentially as described (Ouyang et al., 1997) . Puri®ed recombinant His6-Prk or His6-Prk K52R , expressed through the baculoviral expression system, was assayed for its in vitro kinase activity using substrates such as casein (15 mg/ reaction), GST-Cdc25A (5 mg/reaction), GST-Cdc25B (5 mg/ reaction) or His6-Cdc25c (5 mg/reaction, unless speci®ed otherwise), (1 mg/reaction) or GSTCdc25C S216A (200 ± 256) (1 mg/reaction). The kinase reaction conditions were the same as described previously (Ouyang et al., 1997) .
Metabolic labeling
The PC-3 cells were cultured in RPMI-1640 medium containing 10% FBS to about 80% con¯uence. After two washings with pre-warmed phosphate-free RPMI-1640 medium, asynchronized PC-3 cells (*5610 5 ) were pulsed in the fresh phosphate-free RPMI-1640 medium containing 1.5% dialyzed FBS and 2 mCi [ 32 P]phosphate at 378C for 4 h. After the pulse, cells were washed and lysed in the lysis buer (Ouyang et al., 1997) containing 3 mM okadaic acid.
Phosphopeptide mapping
Radio-labeled Cdc25C protein was obtained either by phosphorylation in vitro by His6-Prk in the presence of 32 P or immunoprecipitated from metabolically-labeled PC-3 cell lysates. After supplementation with the carrier protein (200 mg bovine serum albumin) 32 P-Cdc25C protein was precipitated by the addition of trichloroacetic acid [15% (v/ v) ®nal concentration]. The protein precipitates were washed twice with cold acetone and redissolved in 50 ml NH 4 HCO 3 (200 mM) containing 40 mg tosylphenylanyl chloromethyl ketone (TPCK)-treated trypsin. The dissolved protein samples were digested to completion by TPCK-treated trypsin and then dried under vacuum. The digested peptide samples were redissolved in 5 ml running buer [5.6% (v/v) glacial acetic acid, 2.5% (v/v) formic acid, pH 1.9] and spotted onto cellulose thin layer chromatography (TLC) plates. Peptide fragments were separated ®rst by electrophoresis using a Multiphor II unit (Pharmacia, Piscataway, NJ, USA) and then by chromatography as described (Boyle et al., 1991) . The TLC plates were autoradiographed.
